Toshiba America Medical Systems this month formally introduced Asteion, its latest line of subsecond CT systems. Cleared by the Food and Drug Administration last November (SCAN 11/25/98), Toshiba’s Asteion VR and Asteion VI scanners feature a
Toshiba America Medical Systems this month formally introduced Asteion, its latest line of subsecond CT systems. Cleared by the Food and Drug Administration last November (SCAN 11/25/98), Toshibas Asteion VR and Asteion VI scanners feature a 0.75-second rotation speed and solid-state detectors, with partial reconstruction times as short as half a second using Toshibas image processing algorithms.
The units come equipped with the Tustin, CA-based companys HeliCool x-ray tubes, rated at 4 MHU, and include graphic user interfaces and high-speed power image processors from Silicon Graphics. The scanners support Toshibas Aspire Continuous Imaging real-time scanning protocol. In the future, the Asteion line may be upgraded to Toshibas multislice technology, which will augment possible applications to include advanced CT-angio and cardiac studies, according to Toshiba.
The Asteion line expands Toshibas product offerings, enabling the company to provide both subsecond and multislice scanning at new price points. With the introduction last September of its Aquilion unit, a 0.5-second scanner, Toshiba established a platform for a multislice option to be introduced later this year (SCAN 3/3/99 and 9/16/98). But the Asteion scanners could bridge the gap between conventional single-slice scanners and Aquilion: Although Toshiba did not release a price tag for Asteion, the scanner will likely sell for less than Aquilion.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.